Nocutil (Desmopressin Acetate)

Desmopressin acetate, the active ingredient in Nocutil, is a vasopressin analog presented as an oral formulation for use in patients requiring antidiuretic hormone therapy. It is employed to manage conditions such as central diabetes insipidus, nocturnal enuresis, primary nocturnal polyuria, and certain bleeding disorders.

GNH USA supplies Nocutil as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for export to multiple regions. Clients benefit from reliable logistics and responsive technical support throughout the procurement process.

Desmopressin acetate acts on the antidiuretic hormone pathway to regulate water balance in several clinical conditions. - Central diabetes insipidus: reduces excessive urine output by enhancing water reabsorption in the kidneys. - Nocturnal enuresis: decreases nighttime bedwetting episodes in children and adults. - Primary nocturnal polyuria: lowers nocturnal urine volume, improving sleep continuity. - Von Willebrand disease and mild hemophilia A: raises plasma factor VIII and von Willebrand factor levels to improve hemostasis.

Desmopressin acetate may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Headache: mild to moderate intensity. - Nausea or abdominal discomfort. - Nasal congestion or dryness (if nasal formulation). - Flushing or facial warmth. - Hyponatremia: mild reduction in serum sodium. - Increased thirst.

Serious or Rare Side Effects: - Severe hyponatremia leading to seizures or coma. - Water intoxication with rapid weight gain. - Thromboembolic events such as deep‑vein thrombosis. - Allergic reactions including rash, angioedema, or anaphylaxis. - Cardiac arrhythmias in patients with electrolyte disturbances.

When prescribing desmopressin acetate, clinicians should observe several precautionary measures to ensure patient safety. - Monitor fluid intake: advise patients to limit excessive water consumption. - Assess serum sodium: check baseline and periodic sodium levels, especially in the elderly. - Adjust dose in renal impairment: reduce dosage or increase monitoring in patients with reduced kidney function. - Avoid concomitant use of other antidiuretic agents: such as carbamazepine or chlorpropamide, which may amplify water retention. - Caution in patients with cardiovascular disease: risk of fluid overload and hyponatremia. - Store at below 25°C: keep in the original container, protect from moisture and direct sunlight.

Desmopressin acetate can interact with other medicines that influence water balance or hemostasis.

Major Interactions (Avoid): - Thiazide diuretics or other hyponatremia‑inducing agents: may precipitate severe hyponatremia. - NSAIDs (e.g., ibuprofen, naproxen): can potentiate antidiuretic effect and increase risk of water retention. - Carbamazepine or chlorpropamide: enhance antidiuretic activity and raise hyponatremia risk.

Moderate Interactions (Monitor Closely): - Antihypertensive drugs (e.g., ACE inhibitors, ARBs): monitor blood pressure and fluid status. - Estrogen‑containing oral contraceptives: may increase V2‑receptor sensitivity. - Anticoagulants (e.g., warfarin): monitor coagulation parameters as desmopressin can affect factor VIII levels.